Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Rogers who wrote (2137)	11/12/1998 7:05:00 PM
From: Meisterama	Read Replies (2) \| Respond to of 2887

I, too, have worked in distribution and marketing, specifically in the medical field. And my experience has been that products do not "fly off the shelves," at least when surgical and other less invasive cardiac equipment is involved. And particularly when SOMEONE has to educate the end users and buying decision-makers about the advantages of innovative new products. ABMI hasn't had the resources to prime the pump at the demand end through marketing and education, they do not yet have pricing power, they do not have broad industry recognition, and they do not yet have a broad bundle of products to present to distributors. These are REAL weaknesses, but they have nothing to do with the quality of the products and their ultimate potential. That's why people are more and more speculating that ABMI may be just sold off to a larger company that can more quickly DO something with those fine products. I am not sure that will be the case, myself, although I would surely expect at least a deal or two to unload certain "non-core" (i.e. stent) technologies in exchange for enough cash or other assistance to get the core products selling.